Danish Pain Research Center, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Department of Neurology, Aarhus University Hospital, Aarhus, Denmark; and Department of Pharmacology, Heidelberg University, Heidelberg, Germany.
Physiol Rev. 2021 Jan 1;101(1):259-301. doi: 10.1152/physrev.00045.2019. Epub 2020 Jun 25.
Neuropathic pain caused by a lesion or disease of the somatosensory nervous system is a common chronic pain condition with major impact on quality of life. Examples include trigeminal neuralgia, painful polyneuropathy, postherpetic neuralgia, and central poststroke pain. Most patients complain of an ongoing or intermittent spontaneous pain of, for example, burning, pricking, squeezing quality, which may be accompanied by evoked pain, particular to light touch and cold. Ectopic activity in, for example, nerve-end neuroma, compressed nerves or nerve roots, dorsal root ganglia, and the thalamus may in different conditions underlie the spontaneous pain. Evoked pain may spread to neighboring areas, and the underlying pathophysiology involves peripheral and central sensitization. Maladaptive structural changes and a number of cell-cell interactions and molecular signaling underlie the sensitization of nociceptive pathways. These include alteration in ion channels, activation of immune cells, glial-derived mediators, and epigenetic regulation. The major classes of therapeutics include drugs acting on αδ subunits of calcium channels, sodium channels, and descending modulatory inhibitory pathways.
由躯体感觉神经系统的损伤或疾病引起的神经性疼痛是一种常见的慢性疼痛病症,对生活质量有重大影响。例如,三叉神经痛、痛性多发性神经病、带状疱疹后神经痛和中风后中枢性疼痛。大多数患者会抱怨持续或间歇性的自发性疼痛,例如烧灼感、刺痛感、挤压感,可能伴有诱发疼痛,特别是对轻触和冷感。神经末梢神经瘤、受压神经或神经根、背根神经节和丘脑的异位活动可能是自发性疼痛的基础。诱发疼痛可能会扩散到邻近区域,其潜在的病理生理学涉及外周和中枢敏化。伤害感受通路的敏化是由适应性结构改变和许多细胞-细胞相互作用和分子信号转导引起的。这些包括离子通道的改变、免疫细胞的激活、胶质衍生的介质和表观遗传调控。主要的治疗药物类别包括作用于钙通道的 αδ 亚单位、钠通道和下行调节抑制途径的药物。
Physiol Rev. 2021-1-1
Cent Nerv Syst Agents Med Chem. 2012-12
Handb Exp Pharmacol. 2009
Curr Pain Headache Rep. 2001-4
Curr Drug Targets. 2020
Nature. 2025-8-20
Int J Mol Sci. 2025-7-29